#New York #Israel #Healthcare Conference #Medical Technologies #InMode

InMode to Present at Baird 2025 Global Healthcare Conference

InMode Ltd., a notable player in the field of innovative medical technologies, has confirmed its participation in the upcoming Baird 2025 Global Healthcare Conference. Scheduled for September 10, 2025, the event will take place in New York, where InMode's Chief Financial Officer, Yair Malca, is set to deliver a presentation that will shed light on the company's vision and advancements in medical technology.

Event Details

The session will feature a fireside chat moderated by Jeff Johnson, a Senior Research Analyst at Baird. Attendees can tune in to this informative discussion starting at 8:30 AM Eastern Time. For those unable to attend in person, a live webcast will be available, offering broader access to InMode's insights and strategies.

Not only will Malca present the company's innovative products and services, but he will also engage in one-on-one meetings with investors, providing a platform for more personalized discussions on InMode's performance, future prospects, and investment opportunities. Investors interested in scheduling a meeting can do so through their respective Baird representatives.

About InMode

Established in the realm of medical technologies, InMode has carved out a niche as a leading manufacturer and provider of devices that utilize cutting-edge radio frequency (RF) technology. The company's mission revolves around fostering innovative surgical procedures and enhancing existing treatment modalities, aiming to transform healthcare delivery.

InMode's product line is comprehensive, addressing key areas including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. By leveraging minimally invasive techniques, the firm has developed a unique approach to healthcare that prioritizes patient comfort and recovery while ensuring efficacy and safety.

Technological Innovations

The company’s advanced RF technologies are central to its success, allowing for a new era of surgical interventions and aesthetic procedures that align with modern medical standards. InMode continuously seeks to improve its offerings, ensuring that healthcare professionals and patients alike benefit from enhanced therapeutic options.

Strategic Outlook

Looking ahead, InMode is set to share more about its strategic objectives and revenue projections during the conference. Observers have noted the potential for growth in the medical technology sector, particularly as the demand for innovative and effective treatment solutions increases.

Forward-looking statements from InMode highlight management's outlook and preparations for the future, although they come with the understanding that various risks and uncertainties may impact actual results. Investors are encouraged to consider these factors as they assess their strategies moving forward.

Overall, the Baird 2025 Global Healthcare Conference promises to be a pivotal moment for InMode, as it positions itself at the forefront of medical technology innovation. Attendees will gain a better understanding of the company's commitment to advancing healthcare technologies that ultimately improve patient outcomes.

For more details about the event and InMode's product offerings, interested parties can visit the company's investor relations page or their official website at InMode.